Artivion, Inc., a medical device company specializing in surgical and medical instruments, reported today that it had identified and begun responding to a cybersecurity incident on November 21, 2024.
The incident, which involved the acquisition and encryption of files, prompted the company to take certain systems offline and engage external legal, cybersecurity, and forensic advisors.
According to the company's SEC Form 8-K filing, Artivion is actively working to restore its systems securely and assess any potential notification obligations. While the incident has caused some disruptions to order and shipping processes, as well as to certain corporate operations, these have been largely mitigated. Artivion continues to deliver its products and services to customers.
The company has stated that the cybersecurity incident has not had a material impact on its financial condition or results of operations to date and is not expected to have a material impact in the future. However, Artivion acknowledges that it has incurred and will continue to incur expenses related to the incident's response, and while it believes it has adequate insurance coverage, there will be additional costs not covered by insurance.
Artivion, formerly known as CryoLife Inc (NYSE:AORT)., is incorporated in Delaware and has its principal executive offices in Kennesaw, Georgia.
The news above is based on an SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.